On Thursday, September 25, investors will look at 13 companies in the stock market. Companies like Tata Steel, Polycab India and Akzo Nobel have made big investment and block deals. In addition, companies like Wari Energy, Birla Corp have given new projects and licensing updates. Let’s know about the 13 shares that will be in the eyes of investors in Thursday’s trading session.
Tata steel
Tata Steel, its foreign unit T Steel Holdings Private Limited (TSHP) has invested ₹ 4,054.66 crore and won 457.7 crore shares. TSHP remains a fully owned subsidiary of this company of Tata Group.
Polycab India Limited
Polycab India Limited promoters are planning to sell 0.81% stake through block deal. The value of this deal is around ₹ 887.6 crore. The minimum price has been fixed at ₹ 7,300 per share, which is 3.09% less than the previous trading price.
Wari Energyz Limited
Domestic solar module manufacturer Wari Energy Limited has invested ₹ 300 crore in its subsidiary Wari Energy Solutions Solutions Private Limited (WESSPL). This investment has been made through the rights issue.
Birla Corp
A unit of Birla Corp, RCCPL, has been selected as a favorite bidder for Kanpa-Junapani limestone block of Telangana. This block is spread over 3.38 square kilometers in Adilabad district and proposes 87.05% revenue participation.
Piramal Enterprises Limited
Piramal Enterprises Limited has received approval from NCLT for merger with Piramal Finance. Anand Piramal will be the president of Piramal Finance, while Ajay and Swati Piramal will lead the group.
Akzo Nobel India
The promoter of Akzo Nobel India, Imperial Chemical Industries has sold its 5% stake in ₹ 765 crore through a block deal. Nippon India and WF Asian Smallor Companies Fund were its lead buyers.
Lupine limited
Pharma company Lupine has received an initial approval from the US Food and Drug Administration (FDA) for the generic version of HIV medicine in its Nagpur factory.
Dalmia India
Dalmia India has confirmed that the Enforcement Directorate has temporarily seized land worth ₹ 377.26 crore under the PMLA. The company said it had not affected its operations and will take legal action.
Glenmark Pharma
A subsidiary of Glenmark Pharma has entered into a special licensing agreement with Hengrui Pharma for a new Her2-target cancer drug, Tostuzumber Restecan. Under this, Glenmark will pay $ 18 million in advance. Also, he will also give royalty on payment of up to $ 1.09 billion and drug sales in future.
IPCA Laboratories
IPCA Labs has signed a technology transfer and joint development agreement with the US biosymiller sciences for the next generation monoclonal antibody biosimiller. This product will be produced at the factory in Puerto Rico of BSS. Its first launch is proposed in 2027.
Newgan software technologies limited
The British unit of Newgen Software has Belgian TCS NV. The five -year Master Service Agreement has been signed with. The deal includes cloud hosting, software license and implementation services. This is a completely a commercial transaction.
GPT infrastructure projects
GPT infrastroses have appointed Om Tanti as co-chairman. This decision will be effective from 24 September 2025.
New India Assurance Company Limited
The government company New India Assurance has received a refund of ₹ 249.79 crore for the tax assessment year 2009-10 from the Income Tax Department. This includes an interest of ₹ 8.89 crore.
